However, breast cancer still remains a major public health issue with only three robust biomarkers predicting its response to endocrine (oestrogen receptor and progesterone receptor) or biological therapies (human epidermal growth factor receptor 2 (HER2)). The gene discussed is ERBB2; the disease is breast carcinoma.